DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 91 filers reported holding DYNE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $840,099 | -18.6% | 93,761 | +2.2% | 0.00% | – |
| Q2 2023 | $1,031,986 | +24.5% | 91,732 | +27.5% | 0.00% | – |
| Q1 2023 | $829,106 | +100.0% | 71,971 | +101.2% | 0.00% | – |
| Q4 2022 | $414,528 | -35.7% | 35,766 | -29.6% | 0.00% | – |
| Q3 2022 | $645,000 | +230.8% | 50,819 | +79.5% | 0.00% | – |
| Q2 2022 | $195,000 | -38.3% | 28,309 | -13.6% | 0.00% | – |
| Q1 2022 | $316,000 | -58.5% | 32,772 | -48.8% | 0.00% | – |
| Q4 2021 | $762,000 | +252.8% | 64,019 | +381.2% | 0.00% | – |
| Q3 2021 | $216,000 | -24.7% | 13,303 | -2.5% | 0.00% | – |
| Q2 2021 | $287,000 | +40.0% | 13,638 | +3.3% | 0.00% | – |
| Q1 2021 | $205,000 | -22.6% | 13,205 | +4.5% | 0.00% | – |
| Q4 2020 | $265,000 | – | 12,639 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |